Accuracy of administrative databases in identifying patients with hypertension
- PMID: 20101286
- PMCID: PMC2801913
Accuracy of administrative databases in identifying patients with hypertension
Abstract
Background: Traditionally, the determination of the occurrence of hypertension in patients has relied on costly and time-consuming survey methods that do not allow patients to be followed over time.
Objectives: To determine the accuracy of using administrative claims data to identify rates of hypertension in a large population living in a single-payer health care system.
Methods: Various definitions for hypertension using administrative claims databases were compared with 2 other reference standards: (1) data obtained from a random sample of primary care physician offices throughout the province, and (2) self-reported survey data from a national census.
Results: A case-definition algorithm employing 2 outpatient physician billing claims for hypertension over a 3-year period had a sensitivity of 73% (95% confidence interval [CI] 69%-77%), a specificity of 95% (CI 93%-96%), a positive predictive value of 87% (CI 84%-90%), and a negative predictive value of 88% (CI 86%-90%) for detecting hypertensive adults compared with physician-assigned diagnoses. Compared with self-reported survey data, the algorithm had a sensitivity of 64% (CI 63%-66%), a specificity of 94%(CI 93%-94%), a positive predictive value of 77% (76%-78%), and negative predictive value of 89% (CI 88%-89%). When this algorithm was applied to the entire province of Ontario, the age- and sex-standardized prevalence of hypertension in adults older than 35 years increased from 20% in 1994 to 29% in 2002.
Conclusions: It is possible to use administrative data to accurately identify from a population sample those patients who have been diagnosed with hypertension. Given that administrative data are already routinely collected, their use is likely to be substantially less expensive compared with serial cross-sectional or cohort studies for surveillance of hypertension occurrence and outcomes over time in a large population.
Conflict of interest statement
Competing interests: Dr. Campbell has been paid fees for speaking and for consulting by most pharmaceutical companies in Canada that produce prescription medications to lower blood pressure and has received research funds from Pfizer Canada, Sanofi-Aventis, Merck Frosst, Servier and Bristol-Myers-Squibb for research on the epidemiology of hypertension. Dr. Campbell also chairs the steering committee and executive committee of the Canadian Hypertension Education Program (CHEP) as a volunteer. CHEP has a mandate to improve the treatment and control of hypertension in Canada. Dr. McAlister has received operating grant funding from Pfizer Canada for an ongoing investigator-initiated trial co-funded by the Heart and Stroke Foundation of Canada and Pfizer Canada. The other authors have no potential conflicts of interest.
Figures



References
-
- Tu Jack V, Austin Peter, Naylor C David, Iron Karey, Zhang Hua. Acute myocardial outcomes in Ontario. In: Naylor C, Slaughter P, editors. Cardiovascular health and services in Ontario: an ICES Atlas. 1999. pp. 83–110. http://www.ices.on.ca/file/7_CVA_Chapter5.pdf.
-
- Jong Philip, Gong Yanyan, Liu Peter P, Austin Peter C, Lee Douglas S, Tu Jack V. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation. 2003 Jul 15;108(2):184–191. doi: 10.1161/01.CIR.0000080290.39027.48. - DOI - PubMed
-
- Hill M D, Yiannakoulias N, Jeerakathil T, Tu J V, Svenson L W, Schopflocher D P. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004 Jun 8;62(11):2015–2020. - PubMed
LinkOut - more resources
Full Text Sources